Editorial team
ioQuanta Research Desk
-
Evidence date ·A planned phone trial compares sleep treatment and mindfulness for sleep and thinking
Clinical TrialA not-yet-recruiting registered trial compares four weeks of phone-based insomnia treatment with mindfulness, then tracks sleep and cognition for a year; results are not posted.
-
Evidence date ·What a dasatinib-and-quercetin study can show in secondary progressive MS
Clinical TrialA planned phase 1 study will test intermittent dasatinib and quercetin in progressive MS, focusing first on feasibility and adverse effects.
-
Evidence date ·Could removing dysfunctional support cells help protect aging neurons?
Review or Meta-AnalysisA 2025 review examines senolytics for brain aging. Memory gains in injured mice and mixed human biomarker changes do not establish cognitive benefit in people.
-
Evidence date ·What a tai chi-versus-walking study could reveal about chronic insomnia
Clinical TrialThe registry describes a tai chi-versus-walking study for chronic insomnia, who may join, and six weeks of participation—not a demonstrated benefit.
-
Evidence date ·A rural Taiwan study asks whether wearables fit dementia care
Clinical TrialA Taiwan feasibility study pairs a sleep-tracking wrist device with light-therapy glasses to assess participation, sleep and caregiver burden; no results are posted.
-
Evidence date ·What aging research can change in cells and everyday health
Review or Meta-AnalysisA narrative review compares cellular aging targets with a nine-person human study and explains why biomarkers, risks, and access matter.
-
Evidence date ·How a study in rural Taiwan is examining daily routines and health in later life
Clinical TrialA rural Taiwan study pairs sleep and movement tracking with functional assessments and blood measures to study healthy aging; it is recruiting, with no results posted.
-
Evidence date ·Why clearing chemotherapy-stilled cells might matter in prostate cancer
Peer-Reviewed PaperIn mouse and cell models, ABT-263 reduced IL-20-linked signals after docetaxel; whether this can help patients remains untested.
-
Evidence date ·What gut-made butyrate changed in older adults’ T cells in the lab
Peer-Reviewed PaperButyrate reduced inflammatory signals in older adults’ T-cell cultures. The mouse experiment used mixed stool filtrate, so it could not isolate butyrate’s effect.
-
Evidence date ·How an Alzheimer’s sleep study links daily patterns with a light treatment
Clinical TrialAn Alzheimer's trial compares a near-infrared headband with a sham device and measures reported sleep quality eight weeks after treatment. No results are posted.